National Pharmaceutical Pricing Authority
- All
- News
- Videos
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Cancer Drug Prices Slashed Up To 86% In A Year: Regulator
The other pharma players the prices whose cancer medicines have been reduced are Natco Pharma and Emcure pharmaceuticals among others, it added.
-
Merck Gets Demand Notice From Regulator
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Regulator Approves Norms For Discontinuation Of Scheduled Drugs
To ensure availability of essential drugs in the market, the National Pharmaceutical Pricing Authority (NPPA) is putting in place a framework for alternative arrangements in case of discontinuation of scheduled formulations by private pharmaceutical firms, among other measures.
-
Government Cuts Prices Of 10 Drugs, Brings 8 More Under Control
Government has slashed prices of 10 more drugs while bringing eight new medicines, including paracetamol, under price control for the first time in its bid to cap cost of over 800 plus formulations to make them affordable.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Notices Issued To 263 Pharma Firms For Overcharging In FY16
The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Cancer Drug Prices Slashed Up To 86% In A Year: Regulator
The other pharma players the prices whose cancer medicines have been reduced are Natco Pharma and Emcure pharmaceuticals among others, it added.
-
Merck Gets Demand Notice From Regulator
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Regulator Approves Norms For Discontinuation Of Scheduled Drugs
To ensure availability of essential drugs in the market, the National Pharmaceutical Pricing Authority (NPPA) is putting in place a framework for alternative arrangements in case of discontinuation of scheduled formulations by private pharmaceutical firms, among other measures.
-
Government Cuts Prices Of 10 Drugs, Brings 8 More Under Control
Government has slashed prices of 10 more drugs while bringing eight new medicines, including paracetamol, under price control for the first time in its bid to cap cost of over 800 plus formulations to make them affordable.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Notices Issued To 263 Pharma Firms For Overcharging In FY16
The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.
